News: Search Results
For the past 50 years, the Crohn’s & Colitis Foundation of America has worked to improve the lives of patients living with Crohn’s disease and ulcerative colitis, and to find cures for these debilitating digestive diseases. Today, the Foundation unveiled its new brand, which includes a new brand message, “uniting to care and cure,” and a new logo with a unifying symbol reflecting the organization’s commitment to the IBD community. In addition, the Foundation has amended its name to the Crohn’s & Colitis Foundation to place greater emphasis on its mission to cure these debilitating digestive diseases.
The Great Gutsby Gala to Raise Awareness for IBD
Fifteen New Faculty Members to Present Key Findings about IBD at Crohn’s & Colitis Foundation of America’s Advances in Inflammatory Bowel Diseases Clinical and Research ConferenceJune 8, 2016
The Crohn’s & Colitis Foundation of America (CCFA) and Imedex announced today that 15 new faculty members will present clinical and research findings about Crohn’s disease and ulcerative colitis during the 2016 Advances in Inflammatory Bowel Diseases Clinical and Research Conference (AIBD). AIBD is taking place in Orlando, Florida on December 8-10, 2016. For more information or to register, visit http://www.advancesinibd.com/.
SAN DIEGO, CA– Twenty-five California triathletes crossed the finish line yesterday at the Bass Lake Classic at Yosemite as part of the Crohn’s & Colitis Foundation of America’s Team Challenge endurance training and fundraising program.
The Crohn’s & Colitis Foundation of America (CCFA) announced today that its spin4 crohn’s & colitis cures indoor cycling event will expand to 18 markets across the nation in 2016: Atlanta, Baltimore, Boston, Chicago, Cincinnati, Dallas, Denver, Fairfield/Westchester, Houston, Los Angeles, New York, Orange County, Philadelphia, Pittsburgh, San Diego, San Francisco, Seattle, and Twin Cities.
Today, the Crohn's & Colitis Foundation of America (CCFA) announced the launch of IBD Qorus, a ground-breaking collaboration between patients and their healthcare providers that will lead to enhanced health outcomes and improve the quality of care for inflammatory bowel diseases (IBD) patients.